Non Interventional German Leptomeningeal Disease Register
Condition(s) studied
Investigational drug(s) / intervention(s)
No intervention: Once the patient or their legal guardian has given their written consent, a patient is included in the leptomeningeal disease register. Due to the rapid course of the disease and potential rapid deterioration, the documentation of the course of the disease of the individual patients is to be carried out retrospectively from the data recorded during the course of the clinical routine for the entire duration of the study or until the death of the participating patients after the written consent of the patients. The registry's data sources are the diagnostic findings made at the center and doctors' letters from routine clinical practice. The participating centers carry out the assessment of the participants' performance status so that the patients do not have to complete any study-related questionnaires.
Study summary
The planned multicenter register is intended to create a database in the form of a cancer register on the incidence and course of disease in Germany of leptomeningeal disease, the therapeutic measures administered in the real world and the complications.
Eligibility
Primary outcome measure(s)
- Progression-free survival depending on the treatment modalities — through study completion, an average of 1 year
Only descriptive analyses are planned for the data documented in the register. Absolute and percentage frequencies including two-sided 95% confidence intervals are determined for the frequency of use of certain treatment regimens. - Overall survival depending on the treatment modalities — through study completion, an average of 1 year
Only descriptive analyses are planned for the data documented in the register. Absolute and percentage frequencies including two-sided 95% confidence intervals are determined for the frequency of use of certain treatment regimens.
Trial sites (7)
| Facility | City | Region | Status |
|---|---|---|---|
| Universitätsklinikum Bonn Klinik und Poliklinik für Neurologie | Bonn | Germany | Recruiting |
| Universitätsmedizin Mannheim Universitätsklinikum Mannheim GmbH Klinik für Neurologie | Mannheim | Germany | Recruiting |
| Klinikum rechts der Isar | Technische Universität München; Klinik für Radioonkologie und Strahlentherapie | München | Germany | Recruiting |
| Überörtliche Gemeinschaftspraxis für Hämatologie und Onkologie | Münster | Germany | Not Yet Recruiting |
| Diakonie Klinikum GmbH • Jung-Stilling-KrankenhausAbteilung Neurochirurgie | Siegen | Germany | Recruiting |
| University Hospital Tübingen, Neurooncology | Tübingen | Germany | Recruiting |
| Universitätsklinikum Ulm; Klinik für Innere Medizin III | Ulm | Germany | Recruiting |
More University Hospital Tuebingen trials in Germany
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06146010 on ClinicalTrials.gov ↗ ← All trials in Germany